Lumida
/HTH
⌘K
Hilltop Holdings Inc

Hilltop Holdings Inc

HTH
$38.68USD-1.85%-0.73 today

MARKET CAP

2.3B

P/E (TTM)

15.5x

FWD P/E

17.2x

DAY RANGE

$38 – $39

52W RANGE

$29
$40

AI Summary

Stalk
StalkMedium

HTH has resumed its Stage 2 advance with a clear HH/HL structure above rising short-term EMAs and the 50 DMA. While the medium-term directional asymmetry remains strongly bullish, price is currently consolidating snugly around the EMAs without a fresh trigger. Patience for a meaningful pullback into the rising EMA zone is warranted before committing, even as the long-term uptrend remains intact.

  • Q1 EPS of $0.64 topped consensus by ~30%, net income rose 46% YoY
  • Returned $61M via buybacks and hiked dividend 11%, yielding ~7.6%
  • Forecasted -9% annual earnings growth underperforms 15.6% regional banking
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Hilltop Holdings, Inc. (NYSE: HTH) is a diversified financial services company primarily engaged in banking, mortgage origination, and investment services through subsidiaries like Plains Capital Bank and Hilltop Securities. The company has a significant presence in the Texas market and aims to strategically navigate the evolving financial landscape while addressing the challenges posed by rising competition and fluctuating interest rates. Hilltop's focus on enhancing customer relationships and expanding its service offerings aligns with broader themes in the financial sector, particularly the increasing demand for tailored financial solutions amidst rising economic uncertainties.

Bull says

  • Q1 EPS of $0.64 topped consensus by ~30%, net income rose 46% YoY
  • Returned $61M via buybacks and hiked dividend 11%, yielding ~7.6%
  • Public finance revenues up 20% YoY with $2.6B loan pipeline into 2026
  • FY26 EPS consensus raised from $2.08 to $2.38, indicating recovery potential
  • High earnings yield and book-to-price, manageable leverage, low volatility

Bear says

  • Forecasted -9% annual earnings growth underperforms 15.6% regional banking
  • Anticipated Fed rate cuts may squeeze net interest margins
  • Mortgage origination volumes pressured by intense competition and weak home sales
  • Negative growth and profitability factor exposure hint at execution risk
  • Negative size/liquidity factors raise capital access concerns
  • High short interest and rate sensitivity amplify downside risk

Investment themes with HTH

High Dividend Yield +0.32%

Companies paying above-average dividends

AVGO · JPM · XOM
Buybacks +0.48%

Companies repurchasing their own shares

C · JCI · WFC
Regional Banks +0.50%

FLG · TCBI · ZION

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 02-03-2026neutral

Transcript signals

Bull points

  • For the full year of 2025, Hilltop reported consolidated income attributable to common stockholders of $165.6 million, equating to $2.64 per diluted share, representing growth of 46% and 52% versus the prior year's results, respectively.
  • Total revenues, including both net interest income and non-interest income, increased by 8% to approximately $1.3 billion, while expenses grew by 2%, resulting in positive operating leverage of 6% for the year-end 2025.
  • we do expect that the interest-bearing deposit beta will fall towards 60% to 65% if the Federal Reserve reduces rates an additional two to three times during this portion of the rate cycle.

Bear points

  • The fourth quarter results include $7.8 million provision for credit loss, which reflects the combined impacts of net charge-offs during the period and a modest deterioration in the economic condition outlook.
  • The decline in average deposits was driven by management's decision to return, on average, $397 million of HCS sweep deposits back to Hilltop Securities to be deployed into their FDIC-insured sweep deposit program.
  • some of the significant macro challenges persist, whereby the combination of higher interest rates, home price inflation, insurance, and elevated tax costs continue to pressure volumes and margins.
Read full transcript analysis ›